We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Cormedix Inc
11 own
21 watching
Current Price
$12.49
$0.32
(2.63%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
221.78M
52-Week High
13.85000
52-Week Low
2.89000
Average Volume
1.23M
Dividend Yield
--
P/E Ratio
--
Market Capitalization221.78M52-Week High13.8500052-Week Low2.89000Average Volume1.23MDividend Yield--P/E Ratio--What does the Cormedix Inc do?
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Read More
How much money does Cormedix Inc make?
News & Events about Cormedix Inc.
Globe Newswire
1 year ago
BERKELEY HEIGHTS, N.J., June 28, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced the pricing of its ...
Zolmax
1 year ago
CorMedix Inc. (NASDAQ:CRMD Get Rating) was the target of a large increase in short interest in May. As of May 31st, there was short interest totalling 2,620,000 shares, an increase of 20.7% from the May 15th total of 2,170,000 shares. Based on an average daily volume of 310,900 shares, the short-...
Globe Newswire
1 year ago
BERKELEY HEIGHTS, N.J., May 01, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced that the United States ...
Benzinga
1 year ago
Latest Ratings for CRMD
DateFirmActionFromTo May 2021NeedhamMaintainsBuy Feb 2021NeedhamInitiates Coverage OnBuy Feb 2021Truist SecuritiesMaintainsBuy
View More Analyst Ratings for CRMD
View the Latest Analyst Ratings
read more...
Globe Newswire
1 year ago
BERKELEY HEIGHTS, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced that it will report its ...
Frequently Asked Questions
Frequently Asked Questions
What is Cormedix Inc share price today?
Can Indians buy Cormedix Inc shares?
How can I buy Cormedix Inc shares from India?
Can Fractional shares of Cormedix Inc be purchased?
What are the documents required to start investing in Cormedix Inc stocks?
What is today’s traded volume of Cormedix Inc?
What is today’s market capitalisation of Cormedix Inc?
What is the 52-Week High and Low Range of Cormedix Inc?
What percentage is Cormedix Inc down from its 52-Week High?
What percentage is Cormedix Inc up from its 52-Week Low?
Current Price
$12.49
$0.32
(2.63%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.